MRK
MRK
NYSE · Pharmaceuticals

Merck & Co. Inc.

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$115.48
+1.61 (+1.41%)
As of Jun 22, 9:30 PM ET ·
Analyst Consensus
Buy
36
Analysts
Very High
Coverage
Buy 25 69%
Hold 11 31%
Sell 0 0%
Price Target
Analyst Price Target +37.9% upside
Low Target $113.44
Average Target $159.27
High Target $183.82
Current Price $115.48
Current
$115.48
Target
$159.27
$113.44 $159.27 avg $183.82
Scenario Analysis
Bear Case
$113.44
-1.8%
Low target
Base Case
$159.27
+37.9%
Avg target
Bull Case
$183.82
+59.2%
High target
Risk/Reward
33.5x
Highly favorable
Price in Context
52-Week High
$125.14
-7.7% from high
52-Week Low
$76.66
+50.6% from low
50-Day SMA
$109.24
+5.7% vs SMA
200-Day SMA
$90.33
+27.8% vs SMA
RSI (14)
79.1
Overbought
Target vs 52W High
$159.27
+27.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
 Sell 44 50% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
 Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
 Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
 Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -32.3%